AI for CEOs · Independent decision intelligenceSource-backed reporting · No paid editorial rankings
CEO AI Brief

A concise but evidence-dense briefing service for CEOs governing AI as strategy, capital allocation, operating-model change, and enterprise risk—not as a parade of tools.

CEO briefings

Do not net internal AI gains against customer-facing effects

The SEC Investor Advisory Committee's December 2025 recommendation asks the Commission to consider separate material reporting on AI deployment and effects in internal business operations and consumer-facing matters. It is an advisory committee recommendation, not a Commission rule or an issuer-specific materiality decision. The distinction is still useful for CEOs: an internal productivity gain should not be used to net away a separate customer effect. Management should maintain two evidence tracks and bring each material conclusion to the board and disclosure process on its own terms.

Answer capsule

The SEC Investor Advisory Committee's December 2025 recommendation asks the Commission to consider separate material reporting on AI deployment and effects in internal business operations and consumer-facing matters. It is an advisory committee recommendation, not a Commission rule or an issuer-specific materiality decision. The distinction is still useful for CEOs: an internal productivity gain should not be used to net away a separate customer effect. Management should maintain two evidence tracks and bring each material conclusion to the board and disclosure process on its own terms.

What the source establishes

  • The document says it was approved by the SEC Investor Advisory Committee at its December 4, 2025 meeting.
  • The committee recommends that the Commission consider a materiality-informed framework and separately report AI deployment and effects in internal business operations and consumer-facing matters when material.
  • The recommendation also discusses issuer definitions and board oversight, but it does not say that positive and negative effects can be combined into one net AI-impact conclusion.
  • The document is a committee recommendation to the Commission, not an SEC rule, Commission guidance, issuer filing, or determination that any particular effect is material.

Separate the two effect populations

Maintain an internal-operations record for employee work, cost, capacity, process quality, control, security, resilience, and workforce effects. Maintain a consumer-facing record for product behavior, prices and offers, access, service, safety, privacy, complaints, remediation, and customer outcomes. A single system may appear in both, but the affected population, evidence, consequence, and accountable owner should remain visible. The CEO should reject an enterprise summary that calls AI net positive because internal time savings numerically outweigh a qualitatively different customer harm or unresolved exposure.

Measure each effect against its own baseline

For internal operations, state the prior process, period, population, cost and capacity, quality and control measures, displaced work, reinvestment decision, and distribution across roles. For consumer-facing use, state the prior experience, eligible and excluded customers, channel, price or service treatment, error and override, complaint and remedy, and differential effects. Separate observed measurements from forecasts and provider claims, and preserve uncertainty and attribution limits. The two tracks may inform one strategy decision, but they should not share a denominator or offset each other unless a valid, transparent analysis and decision purpose support that treatment.

Resolve tradeoffs as decisions, not arithmetic

When an initiative creates internal benefit and consumer risk—or the reverse—name the decision maker, affected stakeholders, alternatives, guardrails, stop conditions, and remedy rather than hiding the conflict in a blended score. State which effect is reversible, who bears it, when it occurs, and what evidence could change the recommendation. Escalate material customer, workforce, capital, control, resilience, and reputation consequences through the appropriate executive and board paths. A benefit in one population may justify further analysis or mitigation investment; it does not erase a duty, harm, or uncertainty in another population.

Keep the separation in board and public language

Present internal and consumer-facing deployment stages and effects in adjacent, separately sourced sections of management and board materials. Reconcile any public statement to those same records, including benefits, adverse developments, limitations, and unresolved facts. Label the source document correctly as an advisory committee recommendation and obtain qualified advice on current disclosure duties and materiality. Reopen both tracks when a shared model, data source, product, workforce practice, incident, capital decision, or external requirement changes. Separate evidence does not force public disclosure of every fact; it helps the CEO, board, and disclosure owners make that contextual decision without an opaque net number.

Turn this source into a reviewable decision

For AI for CEOs, use this briefing as a dated decision record rather than a substitute for the source. Preserve Recommendation of the SEC Investor Advisory Committee Regarding the Disclosure of Artificial Intelligence's Impact on Operations, the exact URL, the September 4, 2026 review date, the supported facts above, the editorial interpretation, the limitations, and any buyer-specific evidence. Link that record to the decisions most directly affected: Customer value and product strategy; Operating-model redesign; Board governance and oversight; Enterprise resilience and risk. State whether the source changes the scope, evidence requirement, control, sequence, or only the language used to describe the decision.

Before action, name the accountable owner, affected population and workflow, exact offering or configuration, source data and rights, human decision point, exception and appeal path, complete cost, expected benefit, failure and stop conditions, retained evidence, and next review date. Keep official facts, provider statements, buyer observations, representative tests, measured outcomes, editorial inferences, and unknowns visibly separate. Reopen the record when the source, offer, model, integration, data, policy, population, responsible person, or measured result changes.

Limitations and unknowns

The primary source is an SEC Investor Advisory Committee recommendation approved on December 4, 2025. It recommends Commission action, including separate material discussion of AI deployment and effects in internal operations and consumer-facing matters. It does not prescribe a no-netting accounting method, make a Commission rule or guidance, decide issuer materiality, require disclosure of every AI use, or prove any internal gain, consumer effect, attribution, board effectiveness, control performance, or outcome. Current securities-law requirements and Commission materials, issuer facts and filings, separately defined populations and baselines, reconciled operating, customer, workforce, incident, financial, and control evidence, board and disclosure records, and qualified board, executive, finance, accounting, customer, product, workforce, investor-relations, disclosure, cybersecurity, privacy, regulatory, communications, and legal review control.

Decision test

Ask whether the source changes the decision itself, the evidence required, the implementation sequence, or only the language used to describe an existing capability. Record which claims are directly supported, which are provider statements, which require an independent test, and which remain unknown. A source-linked review should make uncertainty easier to see, not bury it inside a blended score.

Questions to take into review

  • What customer problem becomes meaningfully better?
  • Who bears errors and review work?
  • Which decision rights change?
  • What work disappears, changes, or is created?
  • Which AI matters to strategy or risk?
  • What evidence supports management's claims?
  • Where could one shared AI dependency disrupt several functions?
  • Which residual risks has management accepted?
The publication supports research and executive decision preparation. It does not provide legal, financial, accounting, employment, clinical, cybersecurity, investment, procurement, or implementation advice.